Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

NE3107 in Adults With Neurological Symptoms of Long COVID

  • Read more about NE3107 in Adults With Neurological Symptoms of Long COVID

Signet Therapeutics

By jpalfreyman on Wed, 02/26/2025 - 09:03
  • Read more about Signet Therapeutics

Elixirgen Therapeutics, Inc.

By jpalfreyman on Fri, 02/21/2025 - 10:49
  • Read more about Elixirgen Therapeutics, Inc.

Axcynsis Therapeutics Pte Ltd

By jpalfreyman on Fri, 02/21/2025 - 10:44
  • Read more about Axcynsis Therapeutics Pte Ltd

Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer

  • Read more about Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer

Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue

  • Read more about Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue

TREC@TAMU Cancer Prevention Registry and Repository

  • Read more about TREC@TAMU Cancer Prevention Registry and Repository

Dysbiosis & Long COVID

  • Read more about Dysbiosis & Long COVID

Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID

  • Read more about Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

  • Read more about Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA